U.S. Markets closed

See what the IHS Markit Score report has to say about Jazz Pharmaceuticals PLC.

IHS Markit

Jazz Pharmaceuticals PLC

NASDAQ/NGS:JAZZ

Score: Neutral (52)

5 days at current score.

Downgraded from Positive on November 10th 2017

View full report here!

Summary


  • This company ranked neutral compared to the Healthcare sector with only 1 positive IHS Markit Category
  • Bearish sentiment is low


Bearish sentiment

Short interest | Positive

Short interest is low for JAZZ with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.

Money flow

ETF/Index ownership | Neutral

ETF activity is neutral. ETFs that hold JAZZ had net inflows of $2.10 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing.

Economic sentiment

PMI by IHS Markit | Neutral

According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however.

Credit worthiness

Credit default swap

CDS data is not available for this security.

Please send all inquiries related to the report to score@ihsmarkit.com.

Charts and report PDFs will only be available for 30 days after publishing.

This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.